Bibliography
- XU J, WANG X, ENSIGN B et al: Ion-channel assay technologies: quo vadis? Drug Disc. Today (2001) 6:1278–1287.
- TERSTAPPEN GC: Functional analysis of native and recombinant ion channels using a high capacity nonradioactive rubidium efflux assay. Anal. Biochern (1999) 272:149–155.
- NETZER R, EBNETH A, BISCHOFF U, PONG 0: Screening lead compounds for QT interval prolongation. Drug Disc. Today (2001) 6:78–84.
- SCHROEDER K, NEAGLE B, TREZISE DJ et Ionworks HT: a new high-throughput electrophysiology measurement platform. J. Biornolec. Screening (2003) 8:50-64. In this review the Ionworks HT patch-clamp platform, one of the most used currently, is well described and put in the context of other HT ion-channel technologies.
- PARDO LA, DEL CAMINO D, SANCHEZ A et al.: Oncogenic potential of EAG K(+) channels. EMBOJ (1999) 18:5540–5547.
- GOPALAKRISHNAN M, BUCKNER SA,WHITEAKER KL et al: () (9S) 9 (3 Bromo-4-fluoropheny1)-2,3,5,6,7,9-hexahydrothieno [3,2-b] quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterisation. Pharm. Exp. Ther. (2002) 303:379–386.
- SPLAWSKI I, SHEN J, TIMOTHY KV et al: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 102:1178–1185.
- •An excellent review of the multiple types of ion channels involved in long QT syndrome besides the most famous HERG.